Sign in

or Register now

MyAllergyNetwork.com

    See all of our health sites at www.HealthCentral.com
    Thursday, July 9, 2009
    • Font size
    • Bookmark
    • Save

    Clinical trial: Treating poorly controlled asthma

    (National Institutes of Health) UPDATED 2008-09-05
    In this Phase II clinical trial, researchers will study the safety and effectiveness of the drug reslizumab in patients who have poorly controlled asthma. This national study is currently recruiting non-smoking asthmatics between the ages of 18 and 75.


      Read full story >
    See all Allergy News
    • Font size
    • Bookmark
    • Was this helpful? Yes
    • Save

    People who read this also read...

      Note: All clinical content on this site is physician-reviewed, except material generated by our community members.
      Featuring Content From:
      • Harvard Health Publications
      • A.D.A.M.
      • Thomson PDR
      • Ivanhoe Broadcast News
      • aafa, asthma and allergy foundation of america, asthma

      By using this service, you accept our Terms of Use. Please read them. The consumer health information on MyAllergyNetwork.com is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2005-2009. The HealthCentral Network, Inc. All rights reserved.

      This website is accredited by Health On the Net Foundation. Click to verify.We comply with the HONcode standard for trustworthy health information: verify here.
      • TRUSTe Certified Privacy
      • Health Care Standard of Excellence
      • FREDDIE International Health and Medical Media Award Finalist